Patients. Evidence. Rights.
About the coalition
CBD is a Human Right is an open coalition of patient organisations. It was founded in June 2026 by KOPAC — Patient Association for Cannabis Treatment (Czech Republic), Dosemociones (Spain) and Aube (Canada/France), joined at launch by Verein Medcan (Switzerland) and PatientsCann (United Kingdom). Further patient organisations and individuals may join at any time; the appeal is drafted as an open call.
We exist because of a pattern we believe no patient community should accept: an internal international notification (INCB PP Notice No. 1/2026), followed by increasingly pointed public statements about CBD as a “drug precursor”, followed by an administrative proposal to restrict CBD — moving through a comment procedure rather than open public debate. Whatever one’s view of CBD, decisions about patients’ treatment should be made transparently, on published evidence, with the people affected at the table.
What we are not
We are not an industry campaign. No company funds this coalition’s decisions, no industry or trade-association logo appears on our materials, and we promote no product. We are not against regulation — we ask for proportionate regulation and for enforcement against the genuinely dangerous synthetic products sold outside any rules. And we are not a recreational-cannabis campaign: our members are patient organisations, and our concern is treatment.
Our two names
“CBD is a Human Right” is the name of this campaign — the banner patients march under. The appeal itself carries the formal title “Patients’ Right to Access CBD and Transparent Decision-Making”, because the document addressed to governments must be as precise as the demands it makes.
Join as an organisation
Patient organisations wishing to co-sign write to coalition@cbdhumanright.org. We confirm each organisation’s representative in writing before listing — endorsements on this site are verified, without exception.
- KOPAC (Czech Republic)
- Dosemociones (Spain)
- Aube (Canada/France)
- Verein Medcan (Switzerland)
- PatientsCann (United Kingdom)